Dynex Capital is a buy-rated mREIT positioned to benefit from anticipated Fed rate cuts and a favorable interest rate environment. DX’s portfolio is 93% agency RMBS, offering low credit risk and ...
The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD). Three proteases that are involved in the processing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback